Prosecution Insights
Last updated: August 18, 2026

Examiner: GIAMMONA, FRANCESCA FILIPPA

Tech Center 1600 • Art Units: 1637 1671 1681 1682

This examiner grants 37% of resolved cases

Performance Statistics

37.0%
Allow Rate
-23.0% vs TC avg
139
Total Applications
+55.9%
Interview Lift
1445
Avg Prosecution Days
Based on 73 resolved cases, 2023–2026

Rejection Statute Breakdown

8.5%
§101 Eligibility
10.0%
§102 Novelty
42.3%
§103 Obviousness
30.5%
§112 Clarity

Currently Pending Office Actions

App #TitleStatusAssignee
17925693 METHODS FOR DETECTION OF DONOR-DERIVED CELL-FREE DNA Non-Final OA Natera, Inc.
17600789 IMPROVED LIQUID BIOPSY USING SIZE SELECTION Final Rejection Natera, Inc.
18027087 RANDOM INSERTION GENOME RECONSTRUCTION Final Rejection GOOGLE LLC
18629922 Kaposi sarcoma associated herpesvirus gene function Non-Final OA The Regents of the University of California
17926441 COMPOSITIONS AND METHODS OF A NUCLEASE CHAIN REACTION FOR NUCLEIC ACID DETECTION Non-Final OA THE REGENTS OF THE UNIVERSITY OF CALIFORNIA
18248121 MASSIVELY SCALABLE VIRAL TESTING AND ASYMPTOMATIC SURVEILLANCE Non-Final OA The Board of Trustees of the Leland Stanford Junior University
19326091 COMPOSITIONS AND METHODS OF MAKING GENE EXPRESSION LIBRARIES Non-Final OA 10x Genomics, Inc.
17271866 Methods for Generating Spatially Barcoded Arrays Non-Final OA 10x Genomics, Inc.
17421677 RAPID REVERSE TRANSCRIPTION QUANTITATIVE POLYMERASE CHAIN REACTION Final Rejection Northwestern University
18440197 TARGET ENRICHMENT USING NUCLEIC ACID PROBES FOR scRNAseq Non-Final OA Becton, Dickinson and Company
17619116 DNA METHYLATION BIOMARKERS FOR CANCER DIAGNOSING AND TREATMENT Final Rejection ARIZONA BOARD OF REGENTS ON BEHALF OF THE UNIVERSITY OF ARIZONA
17294179 CRISPR SYSTEM BASED DROPLET DIAGNOSTIC SYSTEMS AND METHODS Final Rejection THE GENERAL HOSPITAL CORPORATION
17789131 PRIMER SET AND METHOD FOR DETECTING TARGET NUCLEIC ACID USING SAME Non-Final OA KANEKA CORPORATION
18000666 SELECTING APTAMERS USING SEQUENCING Non-Final OA Illumina, Inc.
17197836 Nucleic Acid Sequence Analysis from Single Cells Non-Final OA Illumina, Inc.
17905784 NOVEL NUCLEIC ACID TEMPLATE STRUCTURE FOR SEQUENCING Non-Final OA Roche Sequencing Solutions, Inc.
18294322 COMPOSITIONS, KITS, AND METHODS FOR DETECTION OF NUCLEIC ACID SEQUENCE LOADS Non-Final OA Life Technologies Corporation
18732126 SYSTEMS AND METHODS FOR ANALYZING A TARGET MOLECULE Final Rejection AXBIO INC.

Facing This Examiner?

IP Author analyzes examiner patterns and generates tailored response strategies with the highest chance of allowance.

Build Your Strategy

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month